Binovi Technologies Corp. BNVIF

Company Overview

Binovi Technologies Corp. is a Canada-based technology company focused on neuro-vision performance and digital therapeutics for vision training, assessment, and rehabilitation. The company operates in the healthcare technology and sports performance industries, developing software-driven tools intended to improve visual-cognitive performance for athletes, patients, clinicians, and educational users. Binovi’s platform combines eye-tracking, visual assessment protocols, and data analytics to support training and monitoring programs related to vision efficiency, concussion recovery, and neuro-visual performance.

The company’s primary business activities center on its proprietary vision training ecosystem, including digital applications, performance analytics, and subscription-based software services. Revenue has historically been tied to software licensing, enterprise partnerships, and commercialization of vision-training technologies for sports organizations, schools, healthcare providers, and rehabilitation specialists. Binovi evolved from earlier operations under the Eyecarrot Innovations Corp. name before rebranding to Binovi Technologies Corp. as it broadened its positioning around neuro-vision science and cognitive performance applications. Public filings and market disclosures indicate the company has emphasized intellectual property development and strategic partnerships as part of its growth strategy.

Business Operations

Binovi conducts operations primarily through its integrated digital neuro-vision platform and related software products. Its core activities include visual performance testing, eye-tracking integration, cognitive training exercises, and remote performance monitoring tools delivered through cloud-enabled applications. The company’s business model has focused on recurring software and platform revenue, supplemented by enterprise agreements, pilot programs, and technology commercialization initiatives. Public disclosures identify sports performance, education, healthcare rehabilitation, and esports as key target verticals.

The company’s operations are concentrated in North America, though Binovi has pursued broader international commercial opportunities through digital distribution and strategic collaborations. Binovi controls proprietary software assets and intellectual property related to visual training methodologies and neuro-cognitive analytics. Publicly available information references collaborations with sports organizations, educational institutions, and healthcare-focused entities, although the scale and financial contribution of several partnerships are not consistently disclosed across public sources. Data inconclusive based on available public sources regarding the material financial impact of certain partnerships or joint ventures.

Strategic Position & Investments

Binovi’s strategic direction has emphasized the convergence of neuroscience, digital health, and athletic performance technologies. The company has publicly positioned itself within the emerging neurotechnology and digital therapeutics landscape, with a focus on scalable software-based vision assessment and training solutions. Growth initiatives have included expanding enterprise adoption, pursuing licensing opportunities, and integrating data-driven analytics into sports and healthcare applications. The company has also highlighted opportunities related to concussion management, cognitive performance optimization, and remote rehabilitation technologies.

The company has pursued acquisitions and strategic transactions intended to strengthen its intellectual property portfolio and market reach. Historical disclosures reference the integration of technologies and assets connected to its earlier Eyecarrot operations and subsequent platform expansion under the Binovi brand. Binovi has also explored opportunities involving esports and high-performance athletics, seeking differentiation through neuro-visual analytics and training systems. While the company has referenced broader commercialization ambitions in investor communications, publicly available filings provide limited independently verified detail regarding long-term revenue contribution from emerging initiatives.

Geographic Footprint

Binovi Technologies Corp. is headquartered in Canada, with operational and commercial activities primarily focused in North America. The company has targeted customers across Canada and the United States, particularly within sports performance organizations, educational institutions, rehabilitation providers, and technology-driven wellness markets. Its software-centric operating model allows for broader digital accessibility without requiring extensive physical infrastructure in each market.

The company has also communicated ambitions for international reach through digital platform distribution and strategic partnerships. Public disclosures reference engagement opportunities across Europe and other international markets tied to sports performance and healthcare technology applications, though detailed operational segmentation by geography is limited in public filings. Data inconclusive based on available public sources regarding the scale of revenue generated outside North America.

Leadership & Governance

Binovi Technologies Corp.’s leadership has focused on positioning the company at the intersection of vision science, cognitive performance, and digital healthcare technology. Governance and strategy have emphasized intellectual property development, commercialization partnerships, and expansion into performance-oriented healthcare markets. The company’s public communications consistently frame neuro-vision analytics and digital therapeutics as central pillars of its long-term strategic vision.

Key executives and leadership figures identified in public company disclosures include:

• Adam Cegielski – Chief Executive Officer
• David Preiner – Chief Financial Officer
• Shawn Moniz – Director
• Michele Romanow – Former strategic advisor and board-related association referenced in historical company materials

Public filings, including disclosures available through Canadian securities regulators and OTC market documentation, indicate that leadership has prioritized technology commercialization, strategic capital management, and expansion of enterprise relationships. Certain historical executive and board roles have changed over time, and some governance information varies across public sources and reporting periods.